These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19769063)

  • 1. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?].
    Rupprecht T
    MMW Fortschr Med; 2009 Apr; 151(18):8. PubMed ID: 19769063
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublime diagnosis of Lyme neuroborreliosis.
    Segal BM; Logigian EL
    Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
    [No Abstract]   [Full Text] [Related]  

  • 5. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
    Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
    Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
    Tumani H; Cadavid D
    Neurology; 2011 Mar; 76(12):1034-5. PubMed ID: 21422454
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
    Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
    J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
    Lanska DJ
    Neurology; 2008 Jul; 71(2):150; author reply 150-1. PubMed ID: 18606972
    [No Abstract]   [Full Text] [Related]  

  • 9. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
    Ljøstad U; Mygland A
    Neurology; 2008 Jul; 71(2):151; author reply 151-2. PubMed ID: 18606973
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis and Lyme borreliosis.
    Schmutzhard E
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):539-43. PubMed ID: 12422598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients.
    Blanc F; Jaulhac B; Fleury M; de Seze J; de Martino SJ; Remy V; Blaison G; Hansmann Y; Christmann D; Tranchant C
    Neurology; 2007 Sep; 69(10):953-8. PubMed ID: 17785663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
    Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
    Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic difficulties in neuroborreliosis in children].
    Talarek E; Duszczyk E; Zarnowska H
    Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
    Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
    Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
    Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
    [No Abstract]   [Full Text] [Related]  

  • 16. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
    Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
    Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory diagnosis of infection caused by Borrelia burgdorferi].
    Dessau RB; Bangsborg JM; Jensen TP; Hansen K; Lebech AM; Andersen CØ
    Ugeskr Laeger; 2006 Aug; 168(34):2805-7. PubMed ID: 16942701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH; Lager M; Henningsson AJ; Tjernberg I
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
    Vermeersch P; Resseler S; Nackers E; Lagrou K
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.